+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Adenosine"

Heart Failure - Pipeline Insight, 2025 - Product Thumbnail Image

Heart Failure - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Adenosine Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
MTORC1 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

MTORC1 Protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Purinoceptor P2Y12 Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Purinoceptor P2Y12 Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A2B Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A2B Receptor Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A1 Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A1 Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A2A Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A2A Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A2A Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A2A Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A2 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A2 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A3 Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A3 Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A3 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A3 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A1 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A1 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cardiogenic Shock - Pipeline Insight, 2025 - Product Thumbnail Image

Cardiogenic Shock - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
ZONTIVITY Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

ZONTIVITY Market Size, Forecast, and Market Insight - 2032

  • Report
  • March 2024
  • 30 Pages
  • Global
From
Ischemic Stroke Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Ischemic Stroke Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
From
Investigation Report on China's Urokinase Market, 2019-2023 - Product Thumbnail Image

Investigation Report on China's Urokinase Market, 2019-2023

  • Report
  • August 2019
  • 30 Pages
  • China
From
Plavix - Product Thumbnail Image

Plavix

  • Report
  • July 2018
  • 27 Pages
  • Global
From
Loading Indicator

Adenosine is a drug used in the treatment of endocrine and metabolic disorders. It is a purine nucleoside that acts as a neuromodulator, regulating the activity of various neurotransmitters and hormones. Adenosine is used to treat a variety of conditions, including diabetes, obesity, and hypoglycemia. It is also used to treat certain types of heart failure, as well as to reduce the risk of stroke and other cardiovascular diseases. Adenosine is available in both oral and injectable forms. Adenosine is a widely used drug in the endocrine and metabolic disorders market. It is used to treat a variety of conditions, including diabetes, obesity, and hypoglycemia. It is also used to reduce the risk of stroke and other cardiovascular diseases. Adenosine is available in both oral and injectable forms, and is often prescribed in combination with other drugs. Some companies in the Adenosine market include Novartis, Merck, Pfizer, Sanofi, and GlaxoSmithKline. Show Less Read more